Quick links
Journal Information
| Journal Title: | Hip & Pelvis |
|---|---|
| Journal Abbreviation: | Hip Pelvis |
| Acronym: | HP |
| Publication Date: | Vol.24, no.2 (2012) - |
| Frequency: | Quarterly |
| Publisher: | Korean Hip Society |
| Language: | English |
| pISSN: | 2287-3260 |
| eISSN: | 2287-3279 |
| DOI Prefix: | 10.5371/hp |
| Continues: | The Journal of the Korean Hip Society = 대한고관절학회지 |
| Broad Subject Term(s): | Orthopedics |
| MeSH (NLM): | Hip Joint |
| SC (SCI): | Orthopedics |
| Open Access: | OA-nc (https://creativecommons.org/licenses/by-nc/4.0/) |
| Electronic Links: | https://hipandpelvis.or.kr https://www.ncbi.nlm.nih.gov/nlmcatalog/101599815 |
| Indexed/Tracked/Covered By: | PubMed, Pubmed Central, Crossref, Scopus, Google Scholar |
Vol.36 No.1
Mar 01, 2024, pp. 1~75
Most Keyword
?
What is Most Keyword?
- It is most registrated keyword in articles at this journal during for 2 years.
Most View
-
Pathophysiology and Treatment of Gout Arthritis; including Gout Arthritis of Hip Joint: A Literature Review
Yonghan Cha, MD
Hip Pelvis 2024; 36(1): 1-11
, Jongwon Lee, MD , Wonsik Choy, MD , Jae Sun Lee, PhD*,† , Hyun Hee Lee, MD‡ , Dong-Sik Chae, MD‡ -
Treatment of Osteoporosis after Hip Fracture: Survey of the Korean Hip Society
Jung-Wee Park, MD
Hip Pelvis 2024; 36(1): 62-69, Je-Hyun Yoo, MD* , Young-Kyun Lee, MD , Jong-Seok Park, MD† , Ye-Yeon Won, MD‡
Editorial Office
Laboratory tests performed in hip fracture patients. CTX: carboxy-terminal telopeptide of collagen I, PTH: parathyroid hormone, P1NP: procollagen type I N propeptide, U/A: urinalysis.|@|~(^,^)~|@|First-line treatment option for osteoporosis in hip fracture patients. BP: bisphosphonate, PTH: parathyroid hormone, SERM: selective estrogen receptor modulator.|@|~(^,^)~|@|Osteoporosis medication in patients with rebound phenomenon after cessation of denosumab. Ca+Vit. D: calcium and vitamin D, PTH: parathyroid hormone, SERM: selective estrogen receptor modulator.|@|~(^,^)~|@|The most important recognized factor for atypical femoral fracture.|@|~(^,^)~|@|Preferred osteoporosis medications after cessation of bisphosphonate in patients with atypical femoral fracture. PTH: parathyroid hormone, Ca+Vit. D: calcium and vitamin D, SERM: selective estrogen receptor modulator.|@|~(^,^)~|@|Preferred osteoporosis medications in patients with high-risk of atypical femoral fracture. Ca+Vit. D: calcium and vitamin D, SERM: selective estrogen receptor modulator, PTH: parathyroid hormone.
Hip Pelvis 2024;36:62~69 https://doi.org/10.5371/hp.2024.36.1.62
© H&P
© 2024. The Korean Hip Society. Powered by INFOrang Co., Ltd